Get started
Author

M.E.G. Naranjo

Observed names: M E G Naranjo, M. Eugenia G. Naranjo, Maria Eugenia G Naranjo, María EG Naranjo, María Eugenia G Naranjo, María Eugenia G. Naranjo
OpenAlex ID: A5110218750
Interethnic variation of CYP2C19 alleles, ‘predicted’ phenotypes and ‘measured’ metabolic phenotypes across world populations
2015 · I Fricke-Galindo, C Céspedes-Garro, et al. · The Pharmacogenomics Journal · 176
Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations
2014 · Adrián LLerena, Maria Eugenia G Naranjo, et al. · Expert Opinion on Drug Metabolism & Toxicology · 152
High frequency and founder effect of the CYP3A4*20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzyme
2014 · M Apellániz-Ruiz, L Inglada-Pérez, et al. · The Pharmacogenomics Journal · 70
Worldwide interethnic variability and geographical distribution of CYP2C9 genotypes and phenotypes
2015 · Carolina Céspedes-Garro, Ingrid Fricke-Galindo, et al. · Expert Opinion on Drug Metabolism & Toxicology · 68
CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients
2012 · E M Peñas-LLedó, H D Trejo, et al. · Molecular Psychiatry · 46
A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances
2014 · E Peñas-Lledó, S Guillaume, et al. · The Pharmacogenomics Journal · 34
CYP2D6 Gene Polymorphisms and Predicted Phenotypes in Eight Indigenous Groups from Northwestern Mexico
2014 · Blanca Patricia Lazalde-Ramos, Margarita de la Luz Martínez-Fierro, et al. · Pharmacogenomics · 30
High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studies
2016 · M E G Naranjo, F de Andrés, et al. · The Pharmacogenomics Journal · 29
Lessons from Cuba for Global Precision Medicine: CYP2D6 Genotype Is Not a Robust Predictor of CYP2D6 Ultrarapid Metabolism
2017 · Pedro Dorado, Idilio González, et al. · OMICS A Journal of Integrative Biology · 25
CYP2D6-1584C>G Promoter Polymorphism and Debrisoquine Ultrarapid Hydroxylation in Healthy Volunteers
2013 · Adrian LLerena, Pedro Dorado, et al. · Pharmacogenomics · 23
ABCB1 gene polymorphisms and violent suicide attempt among survivors
2014 · E. Peñas-Lledó, S. Guillaume, et al. · Journal of Psychiatric Research · 22
Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: the CEIBA cocktail
2013 · Fernando de Andrés, Martha Sosa-Macías, et al. · Drug metabolism and drug interactions · 17
Characterization of CYP2D6 genotypes and metabolic profiles in the Portuguese population: pharmacogenetic implications
2013 · José Albuquerque, Carolina Ribeiro, et al. · Personalized Medicine · 15
High frequency of CYP2D6 ultrarapid metabolizer genotypes in an Ashkenazi Jewish population from Argentina
2016 · G Moya, P Dorado, et al. · The Pharmacogenomics Journal · 11
CYP2D6 ethnic variability in Hispanics
2014 · Adrián LLerena, Pedro Dorado, et al. · 5
High-performance liquid chromatography method using ultraviolet detection for the quantification of aripiprazole and dehydroaripiprazole in psychiatric patients
2012 · Pedro Dorado, Fernando de Andrés, et al. · Drug metabolism and drug interactions · 5
Impact of cytochrome P450 genes on suicide attempt and risk
2013 · Eva M. Peñas-Lledó, M. Eugenia G. Naranjo, et al. · European Archives of Psychiatry and Clinical Neuroscience · 4
Erratum: CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients
2012 · E M Peñas-LLedó, H D Trejo, et al. · Molecular Psychiatry · 1
PDF
Abcb1 Haplotype (1236tt-2677tt-3435tt) and Use of Violent Suicide Methods Among Attempters.
2015 · E. Peñas-Lledó, S. Guillaume, et al. · European Psychiatry
Increased Cyp2d6-cyp2c19 Metabolic Capacity: Relation to Suicide Attempt Severity as Measured by the Beck Sis-objective Circumstances.
2015 · E. Peñas-Lledó, S. Guillaume, et al. · European Psychiatry
PP142—Influence of the CYP2D6 -1584C>G promoter polymorphism on the phenotype of debrisoquine in healthy volunteers from Cuba and Nicaragua
2013 · M.E.G. Naranjo, P. Dorado, et al. · Clinical Therapeutics
PP145—Distribution of Genetic Variants of CYP2D6 in Amerindians from Northwest Mexico
2013 · B.P. Lazalde-Ramos, C. Galaviz, et al. · Clinical Therapeutics
PDF
PP149— The Ceiba Cocktail for Drug Hydroxylation Phenotyping in Hispanic Populations
2013 · F. De Andres, M.E.G. Naranjo, et al. · Clinical Therapeutics
PP147—CYP2D6 Genetic Polymorphisms Among Three Costa Rican Populations
2013 · C. Céspedes Garro, G. Jiménez-Arce, et al. · Clinical Therapeutics
PP156—CYP2D6 Genotypes and Prediction of Metabolic Profiles in the Portuguese Population: Clinical Implications
2013 · J. Albuquerque, C. Ribeiro, et al. · Clinical Therapeutics
Works count: 26
Citation count: 733
H-index: 13
I10-index: 14
Year
Topic
Type